{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:45Z","timestamp":1787022165043,"version":"build-2736575974"},"reference-count":82,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021828","name":"German Academic Exchange Service","doi-asserted-by":"publisher","award":["91601895"],"award-info":[{"award-number":["91601895"]}],"id":[{"id":"10.13039\/100021828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec040\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer (BC) continues to pose a substantial global health concern, necessitating continuous advancements in therapeutic approaches. Neoadjuvant chemotherapy (NAC) has gained prominence as a key therapeutic strategy, and there is growing interest in the predictive utility of Background Parenchymal Enhancement (BPE) in evaluating the response of breast tumors to NAC. However, the analysis of BPE as a predictive biomarker, along with the techniques used to model BPE changes for accurate and timely predictions of treatment response presents several obstacles. This systematic review aims to thoroughly investigate recent advancements in the analytical methodologies for BPE analysis, and to evaluate their reliability and effectiveness in predicting breast tumor response to NAC, ultimately contributing to the development of personalized and effective therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec041\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive and structured literature search was conducted across key electronic databases, including Cochrane Database of Systematic Reviews, Google Scholar, PubMed, and IEEE Xplore covering articles published up to May 10, 2024. The inclusion criteria targeted studies focusing on breast cancer cohorts treated with NAC, involving both pre-treatment and at least one post-treatment breast dynamic contrast-enhanced Magnetic Resonance Imaging (DCE-MRI) scan, and analyzing BPE utility in predicting breast tumor response to NAC. Methodological quality assessment and data extraction were performed to synthesize findings and identify commonalities and differences among various BPE analytical approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec042\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The search yielded a total of 882 records. After meticulous screening, 78 eligible records were identified, with 13 studies ultimately meeting the inclusion criteria for the systematic review. Analysis of the literature revealed a significant evolution in BPE analysis, from early studies focusing on single time-point BPE analysis to more recent studies adopting longitudinal BPE analysis. The review uncovered several gaps that compromise the accuracy and timeliness of existing longitudinal BPE analysis methods, such as missing data across multiple imaging time points, manual segmentation of the whole-breast region of interest, and over reliance on traditional statistical methods like logistic regression for modeling BPE and pathological complete response (pCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec043\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review provides a thorough examination of current advancements in analytical approaches for BPE analysis in predicting breast tumor response to NAC. The shift towards longitudinal BPE analysis has highlighted significant gaps, suggesting the need for alternative analytical techniques, particularly in the realm of artificial intelligence (AI). Future longitudinal BPE research work should focus on standardization in longitudinal BPE measurement and analysis, through integration of deep learning-based approaches for automated tumor segmentation, and implementation of advanced AI technique that can better accommodate varied breast tumor responses, non-linear relationships and complex temporal dynamics in BPE datasets, while also handling missing data more effectively. Such integration could lead to more precise and timely predictions of breast tumor responses to NAC, thereby enhancing personalized and effective breast cancer treatment strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0317240","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:21:46Z","timestamp":1741353706000},"page":"e0317240","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advances in analytical approaches for background parenchymal enhancement in predicting breast tumor response to neoadjuvant chemotherapy: A systematic review"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4979-3836","authenticated-orcid":true,"given":"Julius","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Malla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benard","family":"Shibwabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"19","key":"pone.0317240.ref001","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","article-title":"Past, present, and future challenges in breast cancer treatment","volume":"32","author":"GW Sledge","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0317240.ref002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Y Xu","year":"2023","journal-title":"Sci Data"},{"issue":"1","key":"pone.0317240.ref003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019","volume":"14","author":"L Lin","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"6","key":"pone.0317240.ref004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0317240.ref005","doi-asserted-by":"crossref","first-page":"14123","DOI":"10.1038\/s41598-021-93592-z","article-title":"Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs","volume":"11","author":"MC Comes","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0317240.ref006","doi-asserted-by":"crossref","first-page":"44673","DOI":"10.1038\/srep44673","article-title":"Neoadjuvant chemotherapy creates surgery opportunities for inoperable locally advanced breast cancer.","volume":"7","author":"M Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0317240.ref007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/2211738507666190122111224","article-title":"Drug combinations in breast cancer therapy","volume":"7","author":"FA Fisusi","year":"2019","journal-title":"Pharm Nanotechnol"},{"issue":"3","key":"pone.0317240.ref008","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.soc.2014.03.006","article-title":"Neoadjuvant therapy in the treatment of breast cancer","volume":"23","author":"M Teshome","year":"2014","journal-title":"Surg Oncol Clin N Am"},{"issue":"Suppl 1","key":"pone.0317240.ref009","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.breast.2017.06.038","article-title":"Neoadjuvant therapy for triple negative and HER2-positive early breast cancer","volume":"34","author":"N Harbeck","year":"2017","journal-title":"Breast"},{"issue":"2","key":"pone.0317240.ref010","first-page":"183","article-title":"Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET\/CT-RECIST 1.1 vs. PERCIST 1.0","volume":"80","author":"K Kitajima","year":"2018","journal-title":"Nagoya J Med Sci"},{"issue":"2","key":"pone.0317240.ref011","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/mp.15428","article-title":"Assessment of breast cancer response to neoadjuvant chemotherapy based on ultrasound backscattering envelope statistics","volume":"49","author":"Z Klimonda","year":"2022","journal-title":"Med Phys"},{"issue":"14","key":"pone.0317240.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143521","article-title":"Assessment and prediction of response to neoadjuvant chemotherapy in breast cancer: A comparison of imaging modalities and future perspectives","volume":"13","author":"V Romeo","year":"2013","journal-title":"Cancers (Basel)"},{"key":"pone.0317240.ref013","first-page":"6639763","article-title":"Impact of Pathologic complete response following neoadjuvant chemotherapy\u2009\u00b1\u2009trastuzumab in locally advanced breast cancer","author":"T Al-Tweigeri","year":"2021","journal-title":"J Oncol"},{"issue":"11","key":"pone.0317240.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113271","article-title":"Breast cancer heterogeneity and response to novel therapeutics","volume":"12","author":"M Baliu-Pique","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"pone.0317240.ref015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/annonc\/mdu118","article-title":"Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994\/BIG 1-00 phase III trial","volume":"25","author":"H Bonnefoi","year":"2014","journal-title":"Ann Oncol"},{"issue":"15","key":"pone.0317240.ref016","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"G von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"pone.0317240.ref017","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10549-011-1660-6","article-title":"Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)","volume":"132","author":"M Zambetti","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"pone.0317240.ref018","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","article-title":"Neoadjuvant chemotherapy for operable breast cancer","volume":"94","author":"JSD Mieog","year":"2007","journal-title":"Br J Surg"},{"issue":"2","key":"pone.0317240.ref019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2214\/AJR.09.4110","article-title":"Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know","volume":"195","author":"M Nishino","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"pone.0317240.ref020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tranon.2015.11.016","article-title":"Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI","volume":"9","author":"A Tudorica","year":"2016","journal-title":"Transl Oncol"},{"issue":"5","key":"pone.0317240.ref021","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clbc.2011.06.007","article-title":"Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy","volume":"11","author":"J De Los Santos","year":"2011","journal-title":"Clin Breast Cancer"},{"key":"pone.0317240.ref022","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clinimag.2019.01.021","article-title":"Ultrasound echogenicity reveals the response of breast cancer to chemotherapy","volume":"55","author":"K Dobruch-Sobczak","year":"2019","journal-title":"Clin Imaging"},{"issue":"4","key":"pone.0317240.ref023","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0043-111589","article-title":"Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, shear wave elastography and MRI","volume":"39","author":"A Evans","year":"2018","journal-title":"Ultraschall Med"},{"issue":"21","key":"pone.0317240.ref024","first-page":"1","article-title":"Molecular biomarkers predict pathological complete response of neoadjuvant chemotherapy in breast cancer patients: Review","volume":"13","author":"AJA Freitas","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"pone.0317240.ref025","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3346\/jkms.2015.30.6.808","article-title":"Treatment response evaluation of breast cancer after neoadjuvant chemotherapy and usefulness of the imaging parameters of MRI and PET\/CT","volume":"30","author":"YY An","year":"2015","journal-title":"J Korean Med Sci"},{"issue":"7","key":"pone.0317240.ref026","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/RLU.0000000000001684","article-title":"Multiparametric evaluation of treatment response to neoadjuvant chemotherapy in breast cancer using integrated PET\/MR","volume":"42","author":"J Wang","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"2","key":"pone.0317240.ref027","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"BN Dontchos","year":"2015","journal-title":"Radiology"},{"issue":"4","key":"pone.0317240.ref028","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11040256","article-title":"Response predictivity to neoadjuvant therapies in breast cancer: A qualitative analysis of background parenchymal enhancement in DCE-MRI","volume":"11","author":"D La Forgia","year":"2021","journal-title":"J Pers Med"},{"key":"pone.0317240.ref029","doi-asserted-by":"crossref","unstructured":"Rella R, Contegiacomo A, Bufi E, Mercogliano S, Belli P, Manfredi R. Background parenchymal enhancement and breast cancer: a review of the emerging evidences about its potential use as imaging biomarker. 2020.","DOI":"10.1259\/bjr.20200630"},{"issue":"1","key":"pone.0317240.ref030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmri.26762","article-title":"Background parenchymal enhancement on breast MRI: A comprehensive review","volume":"51","author":"GJ Liao","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"pone.0317240.ref031","article-title":"\u00ae Magnetic Resonance Imaging.","volume-title":"ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System","author":"EA Morris","year":"2013"},{"issue":"43","key":"pone.0317240.ref032","doi-asserted-by":"crossref","first-page":"e12965","DOI":"10.1097\/MD.0000000000012965","article-title":"Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy: Association with pathologic complete response","volume":"97","author":"J-M Dong","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"pone.0317240.ref033","doi-asserted-by":"crossref","first-page":"e3000","DOI":"10.1097\/MD.0000000000003000","article-title":"Background parenchymal enhancement on preoperative magnetic resonance imaging: association with recurrence-free survival in breast cancer patients treated with neoadjuvant chemotherapy","volume":"95","author":"JS Choi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"pone.0317240.ref034","doi-asserted-by":"crossref","DOI":"10.1007\/s40134-021-00386-2","article-title":"Background parenchymal enhancement on breast MRI: assessment and clinical implications","author":"JS Chalfant","year":"2021"},{"issue":"9","key":"pone.0317240.ref035","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.mri.2013.07.014","article-title":"Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI","volume":"31","author":"J-H Chen","year":"2013","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"pone.0317240.ref036","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tranon.2015.04.001","article-title":"Background parenchymal enhancement of the contralateral normal breast: association with tumor response in breast cancer patients receiving neoadjuvant chemotherapy","volume":"8","author":"JH Chen","year":"2015","journal-title":"Transl Oncol"},{"key":"pone.0317240.ref037","article-title":"Association between background parenchymal enhancement and pathologic complete remission throughout the neoadjuvant chemotherapy in breast cancer patients","author":"C You","year":"2017"},{"key":"pone.0317240.ref038","article-title":"Relationship between background parenchymal enhancement on breast MRI and pathological tumor response in breast cancer patients receiving neoadjuvant chemotherapy","author":"SJ Oh","year":"2018"},{"issue":"3","key":"pone.0317240.ref039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/annonc\/mdm509","article-title":"Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy","volume":"19","author":"M Colleoni","year":"2008","journal-title":"Ann Oncol"},{"issue":"3","key":"pone.0317240.ref040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/radiol.2015150006","article-title":"Breast cancer: influence of taxanes on response assessment with dynamic contrast-enhanced MR Imaging","volume":"277","author":"S Schrading","year":"2015","journal-title":"Radiology"},{"issue":"6","key":"pone.0317240.ref041","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/tbj.12002","article-title":"Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging","volume":"18","author":"V King","year":"2012","journal-title":"Breast J"},{"key":"pone.0317240.ref042","unstructured":"Ghazi MM, Nielsen M, Pai A, Cardoso MJ, Modat M, Ourselin S, et al. Robust training of recurrent neural networks to handle missing data for disease progression modeling. 2018."},{"issue":"2","key":"pone.0317240.ref043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijrobp.2021.08.007","article-title":"Logistic regression in clinical studies","volume":"112","author":"EC Zabor","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0317240.ref044","unstructured":"Schreiber-Gregory D, Bader K. Logistic and linear regression assumptions: violation recognition and control. 2018."},{"key":"pone.0317240.ref045","unstructured":"Higgins J, Lasserson T, Chandler J, Tovey D, C. R. Methodological expectations of Cochrane intervention reviews. 2024."},{"issue":"3","key":"pone.0317240.ref046","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"MJ Page","year":"2021","journal-title":"PLoS Med"},{"key":"pone.0317240.ref047","doi-asserted-by":"crossref","DOI":"10.1016\/j.infsof.2015.03.007","article-title":"Guidelines for conducting systematic mapping studies in software engineering: An update.","author":"K Petersen","year":"2015"},{"issue":"4","key":"pone.0317240.ref048","first-page":"524","article-title":"Risk on bias assessment: (6) A Revised Tool for the Quality Assessment on Diagnostic Accuracy Studies (QUADAS-2)","volume":"39","author":"YJ Qu","year":"2018","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"8","key":"pone.0317240.ref049","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"PF Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0317240.ref050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.tranon.2017.07.005","article-title":"Association between background parenchymal enhancement and pathologic complete remission throughout the neoadjuvant chemotherapy in breast cancer patients","volume":"10","author":"C You","year":"2017","journal-title":"Transl Oncol"},{"issue":"4","key":"pone.0317240.ref051","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jbi\/wbaa028","article-title":"Predictive value of breast MRI background parenchymal enhancement for neoadjuvant treatment response among HER2- patients","volume":"2","author":"VA Arasu","year":"2020","journal-title":"J Breast Imaging"},{"issue":"10","key":"pone.0317240.ref052","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.diii.2020.05.010","article-title":"Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"101","author":"R Rella","year":"2020","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"pone.0317240.ref053","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1148\/radiol.2021203645","article-title":"Breast MRI during neoadjuvant chemotherapy: Lack of background parenchymal enhancement suppression and inferior treatment response","volume":"301","author":"N Onishi","year":"2021","journal-title":"Radiology"},{"issue":"6","key":"pone.0317240.ref054","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00330-015-4011-x","article-title":"Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response","volume":"26","author":"H Preibsch","year":"2016","journal-title":"Eur Radiol"},{"issue":"7","key":"pone.0317240.ref055","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0284185117738560","article-title":"Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer","volume":"59","author":"C You","year":"2018","journal-title":"Acta Radiol"},{"key":"pone.0317240.ref056","doi-asserted-by":"crossref","DOI":"10.21203\/rs.3.rs-3374242\/v1","article-title":"Automated quantification of background parenchymal enhancement in longitudinal dynamic contrast-enhanced MRI for predicting neo-adjuvant chemotherapy response in breast cancer","author":"X Huang","year":"2023"},{"issue":"2","key":"pone.0317240.ref057","doi-asserted-by":"crossref","first-page":"101","DOI":"10.18383\/j.tom.2020.00009","article-title":"Comparison of segmentation methods in assessing background parenchymal enhancement as a biomarker for response to neoadjuvant therapy","volume":"6","author":"AA-T Nguyen","year":"2020","journal-title":"Tomography"},{"issue":"1","key":"pone.0317240.ref058","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41523-020-00203-7","article-title":"Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL","volume":"6","author":"W Li","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"3","key":"pone.0317240.ref059","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10549-005-9008-8","article-title":"High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer","volume":"94","author":"SC Abrial","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"27","key":"pone.0317240.ref060","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"S Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0317240.ref061","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jmri.25895","article-title":"Comparison between qualitative and quantitative assessment of background parenchymal enhancement on breast MRI","volume":"47","author":"AC Pujara","year":"2018","journal-title":"J Magn Reson Imaging"},{"issue":"1056","key":"pone.0317240.ref062","doi-asserted-by":"crossref","first-page":"20150417","DOI":"10.1259\/bjr.20150417","article-title":"Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores","volume":"88","author":"A Tagliafico","year":"2015","journal-title":"Br J Radiol"},{"issue":"1070","key":"pone.0317240.ref063","doi-asserted-by":"crossref","first-page":"20160542","DOI":"10.1259\/bjr.20160542","article-title":"Evaluation of background parenchymal enhancement on breast MRI: a systematic review","volume":"90","author":"B Bignotti","year":"2017","journal-title":"Br J Radiol"},{"key":"pone.0317240.ref064","article-title":"Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?","author":"JY Kim","year":"2015"},{"key":"pone.0317240.ref065","doi-asserted-by":"crossref","unstructured":"Dalm\u0131s MU, Litjens G, Holland K, Setio A, Mann R, Karssemeijer N, et al. Using deep learning to segment breast and fibroglandular tissue in MRI volumes. 2016.","DOI":"10.1002\/mp.12079"},{"issue":"1","key":"pone.0317240.ref066","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/mp.14581","article-title":"Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols","volume":"48","author":"D Wei","year":"2021","journal-title":"Med Phys"},{"issue":"1","key":"pone.0317240.ref067","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10278-018-0114-7","article-title":"Fully automated convolutional neural network method for quantification of breast MRI fibroglandular tissue and background parenchymal enhancement","volume":"32","author":"R Ha","year":"2019","journal-title":"J Digit Imaging"},{"issue":"1","key":"pone.0317240.ref068","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/AJR.20.23804","article-title":"Quantitative measures of background parenchymal enhancement predict breast cancer risk","volume":"217","author":"BL Niell","year":"2021","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"pone.0317240.ref069","doi-asserted-by":"crossref","first-page":"19185","DOI":"10.1038\/s41598-019-55820-5","article-title":"Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer","volume":"9","author":"S Moliere","year":"2019","journal-title":"Sci Rep"},{"key":"pone.0317240.ref070","first-page":"234","article-title":"U-Net: Convolutional networks for biomedical image segmentation.","author":"O Ronneberger","year":"2015","journal-title":"Proceedings of the International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI)."},{"issue":"6","key":"pone.0317240.ref071","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/jmri.28679","article-title":"Deep learning-based segmentation of locally advanced breast cancer on MRI in relation to residual cancer burden: a multi-institutional cohort study","volume":"58","author":"MHA Janse","year":"2023","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"pone.0317240.ref072","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.acra.2019.01.012","article-title":"Automatic breast and fibroglandular tissue segmentation in breast MRI using deep learning by a fully-convolutional residual neural network U-Net","volume":"26","author":"Y Zhang","year":"2019","journal-title":"Acad Radiol"},{"key":"pone.0317240.ref073","article-title":"Deep learning-based prediction of response to HER2-targeted neoadjuvant chemotherapy from pre-treatment dynamic breast MRI: A multi-institutional validation study","author":"N Braman","year":"2020"},{"issue":"4","key":"pone.0317240.ref074","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4103\/ijd.IJD_296_17","article-title":"Brief overview of multivariate methods","volume":"62","author":"A Hazra","year":"2017","journal-title":"Indian J. Dermatol"},{"issue":"3","key":"pone.0317240.ref075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1442-2042.2003.00589.x","article-title":"Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer","volume":"10","author":"K Fujikawa","year":"2003","journal-title":"Int J Urol"},{"issue":"3","key":"pone.0317240.ref076","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/apps.12435","article-title":"Using machine learning to analyze longitudinal data: A tutorial guide and best\u2010practice recommendations for social science researchers","volume":"72","author":"A Sheetal","year":"2022","journal-title":"Appl.\u00a0Psychol"},{"issue":"3","key":"pone.0317240.ref077","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1460458217733288","article-title":"Challenges associated with missing data in electronic health records: A case study of a risk prediction model for diabetes using data from Slovenian primary care","volume":"25","author":"G Stiglic","year":"2019","journal-title":"Health Informatics J"},{"key":"pone.0317240.ref078","doi-asserted-by":"crossref","first-page":"103576","DOI":"10.1016\/j.jbi.2020.103576","article-title":"A deep learning-based, unsupervised method to impute missing values in electronic health records for improved patient management","volume":"111","author":"D Xu","year":"2020","journal-title":"J Biomed Inform"},{"issue":"1","key":"pone.0317240.ref079","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1038\/s41598-018-24271-9","article-title":"Recurrent neural networks for multivariate time series with missing values","volume":"8","author":"Z Che","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0317240.ref080","first-page":"900","article-title":"Recurrent neural network based time-series modeling for long-term prognosis following acute traumatic brain injury","author":"A Nayebi","year":"2022","journal-title":"AMIA Annu Symp Proc"},{"issue":"5","key":"pone.0317240.ref081","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/bimj.202000393","article-title":"Missing data imputation in clinical trials using recurrent neural network facilitated by clustering and oversampling","volume":"64","author":"HN Haliduola","year":"2022","journal-title":"Biometrics"},{"issue":"2","key":"pone.0317240.ref082","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.artmed.2010.05.002","article-title":"Missing data imputation using statistical and machine learning methods in a real breast cancer problem","volume":"50","author":"JM Jerez","year":"2010","journal-title":"Artif Intell Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T13:22:20Z","timestamp":1741353740000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0317240"}},"subtitle":[],"editor":[{"given":"Jiang","family":"Gui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0317240","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}